964-10185-97959
4 vaccinations
4 coded responses
51 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 554 / MN
- Registered
- 2021-06-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
MYB-38811-38619
Child or adolescent in my care · Male · 2022-08-18
QQ8-17628-87589
Child or adolescent in my care · Male · 2022-08-18
NUY-23146-91902
Child or adolescent in my care · Male · 2022-08-18
Timeline
-
2021-06-04
Registered in v-safe
-
2021-06-04
Dose 1 — Pfizer-BioNTech
- 2021-06-04
- 2021-06-05
- 2021-06-06
- 2021-06-07
- 2021-06-08
- 2021-06-09
- 2021-06-10
- 2021-06-11
- 2021-06-18
-
2021-06-25
Dose 2 — Pfizer-BioNTech
- 2021-06-25
-
2021-06-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-06-27
- 2021-06-28
- 2021-06-29
- 2021-06-30
- 2021-07-01
- 2021-07-02
- 2021-07-09
- 2021-07-16
- 2021-07-23
- 2021-07-30
- 2021-08-06
- 2021-09-24
- 2021-12-24
-
2022-01-06
Dose 3 — Pfizer-BioNTech
- 2022-01-06
- 2022-01-07
-
2022-01-09
Survey response — days 1–6 daily, dose 3MedDRA: Discomfort — Feeling: Good · Muscle or body achesFree text: Feel discomfort in the uderarm area where lymph nodes areMedDRA releases: 2024-11 · check-in free text available
- 2022-01-10
- 2022-01-11
- 2022-01-12
- 2022-01-13
- 2022-01-20
-
2022-01-27
Survey response — day 21, dose 3MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: GoodFree text: Sore throat, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-02-03
- 2022-02-10
- 2022-02-17
- 2022-04-08
-
2022-07-07
Survey response — 6 months, dose 3MedDRA: Cough, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend schoolFree text: Sore throat, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-09-20
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-22
- 2022-09-23
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-10-06
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-11-01
-
2022-12-20
Survey response — 3 months, dose 4MedDRA: Headache, Rhinorrhoea — Feeling: GoodFree text: Runny nose, headacheMedDRA releases: 2024-11 · check-in free text available
- 2023-03-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-04 | Pfizer-BioNTech | |
| 2 | 2021-06-25 | Pfizer-BioNTech | No |
| 3 | 2022-01-06 | Pfizer-BioNTech | No |
| 4 | 2022-09-20 | Pfizer-BioNTech | Flu |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Feel discomfort in the uderarm area where lymph nodes are
Release 11 — day 21, dose 3
Symptoms: Sore throat, runny nose
Release 12 — 6 months, dose 3
Symptoms: Sore throat, cough
Release 12 — 3 months, dose 4
Symptoms: Runny nose, headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Discomfort | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release